Loading stock data...

Dr. Agarwal's Eye Hospital Limited

BSE: DRAGARWQ

BSE
4,661.70 34.20 (0.74%)

Prev Close

4627.5

Open Price

4698.95

Volume

1,009

Today Low / High

4623.2 / 4735

52 WK Low / High

3512.6 / 6392

Range

4,429 - 4,895

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4661.7, reflecting a change of 34.2 (0.73906%). The expected target range on the BSE is 4,429 - 4,895. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

20 Feb 4,814.00 -2.65%
19 Feb 4,799.00 -0.57%
18 Feb 4,780.00 0.16%
17 Feb 4,745.95 0.68%
16 Feb 4,725.00 0.45%
13 Feb 4,736.05 0.14%
12 Feb 4,800.00 0.67%
11 Feb 4,850.00 -0.20%
10 Feb 4,714.50 2.57%
09 Feb 4,700.00 0.24%
06 Feb 4,700.00 -0.24%
05 Feb 4,738.30 -1.19%
04 Feb 4,751.00 0.88%
03 Feb 4,763.45 -1.82%
02 Feb 4,626.00 0.96%
01 Feb 4,750.15 -1.07%
30 Jan 4,552.00 2.16%
29 Jan 4,665.05 -0.96%
28 Jan 4,646.00 0.21%

Dr. Agarwal's Eye Hospital Limited Graph

Dr. Agarwal's Eye Hospital Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dr. Agarwal's Eye Hospital Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4,661.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 4,661.70 4,708.32 4,237.49 - 5,179.15
4,754.93 3,803.95 - 5,705.92
4,801.55 3,361.09 - 6,242.02
Bearish Scenario 4,661.70 4,615.08 4,153.57 - 5,076.59
4,568.47 3,654.77 - 5,482.16
4,521.85 3,165.29 - 5,878.40

Overview of Dr. Agarwal's Eye Hospital Limited

ISIN

INE934C01018

Industry

Medical - Care Facilities

Vol.Avg

1,293

Market Cap

22,026,315,000

Last Dividend

6.5

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

-438.45

DCF

5,125

Financial Ratios Every Investor Needs

Stock Dividend of DRAGARWQ

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-11-07 November 07, 25 3 3 2025-11-07 2025-11-29
2025-09-18 September 18, 25 3.5 3.5 2025-09-18 2025-10-24
2024-11-08 November 08, 24 2.5 2.5 2024-11-08 2024-11-28
2023-10-31 October 31, 23 2.5 2.5 2023-10-31 2023-11-18
2023-09-14 September 14, 23 3 3 2023-09-14 2023-10-20

Stock Rating Details for DRAGARWQ

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 397.15 Cr 260.66 Cr 136.49 Cr 0.3437 0.00 Cr 4.45 Cr 79.05 Cr 54.65 Cr 116.28 123.59 Cr 0.1376
2024-03-31 319.30 Cr 216.36 Cr 102.94 Cr 0.3224 0.00 Cr 52.31 Cr 66.46 Cr 46.36 Cr 98.64 95.96 Cr 0.1452
2023-03-31 267.23 Cr 60.96 Cr 206.27 Cr 0.7719 0.00 Cr 42.24 Cr 56.22 Cr 36.92 Cr 78.55 77.62 Cr 0.1382
2022-03-31 200.96 Cr 46.64 Cr 154.32 Cr 0.7679 0.00 Cr 31.69 Cr 38.56 Cr 24.10 Cr 51.29 59.92 Cr 0.1199
2021-03-31 139.56 Cr 32.50 Cr 29.24 Cr 0.2095 0.00 Cr 24.52 Cr 12.26 Cr -1.44 Cr -3.06 30.96 Cr -0.0103

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 12.17 Cr 613.32 Cr 403.71 Cr 209.6100 Cr 333.16 Cr 320.99 Cr 13.40 Cr 493.08 Cr 0.00 Cr 0.00 Cr 10.03 Cr 86.9800 Cr
2024-03-31 32.88 Cr 495.76 Cr 338.61 Cr 157.1500 Cr 268.02 Cr 235.14 Cr 10.70 Cr 416.60 Cr 1.84 Cr 0.00 Cr 1.05 Cr 80.7700 Cr
2023-03-31 27.38 Cr 389.94 Cr 276.60 Cr 113.3400 Cr 232.47 Cr 205.09 Cr 6.00 Cr 325.04 Cr 1.08 Cr 0.00 Cr 4.28 Cr 55.0800 Cr
2022-03-31 28.11 Cr 314.01 Cr 235.84 Cr 78.1700 Cr 193.46 Cr 165.35 Cr 5.73 Cr 244.63 Cr 9.51 Cr 0.00 Cr 2.30 Cr 53.3500 Cr
2021-03-31 21.52 Cr 155.23 Cr 100.57 Cr 54.6628 Cr 67.55 Cr 46.02 Cr 5.21 Cr 95.82 Cr 10.03 Cr 0.00 Cr 0.00 Cr 48.5997 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 91.3600 Cr -132.8400 Cr 19.7600 Cr -11.5000 Cr -20.8000 Cr 12.1700 Cr -102.8600 Cr 54.6500 Cr 45.0500 Cr -2.3500 Cr -3.6500 Cr
2024-03-31 90.4600 Cr -70.9600 Cr -14.0000 Cr 19.1400 Cr 5.5000 Cr 32.8800 Cr -71.3200 Cr 46.3600 Cr 7.4700 Cr -2.5800 Cr -3.7500 Cr
2023-03-31 69.6200 Cr -70.6100 Cr 0.2600 Cr -1.2200 Cr -0.7300 Cr 27.3800 Cr -70.8400 Cr 36.9200 Cr 11.8900 Cr -1.4100 Cr -0.2700 Cr
2022-03-31 56.6800 Cr -46.2800 Cr -3.8100 Cr 9.9500 Cr 6.5900 Cr 28.1100 Cr -46.7300 Cr 24.1000 Cr 10.3100 Cr -0.0171 Cr -0.5100 Cr
2021-03-31 33.8734 Cr -10.9681 Cr -7.5999 Cr 22.6910 Cr 15.3054 Cr 21.5242 Cr -11.1824 Cr -1.4386 Cr 3.9724 Cr -0.0358 Cr 2.7623 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 116.22 Cr 76.63 Cr 39.59 Cr 0.3406 22.71 Cr 17.28 Cr 35.76 34.37 Cr 0.1487
2025-09-30 117.72 Cr 72.24 Cr 45.48 Cr 0.3863 28.77 Cr 19.32 Cr 41.04 40.76 Cr 0.1641
2025-06-30 116.92 Cr 48.32 Cr 68.60 Cr 0.5867 26.55 Cr 17.26 Cr 36.72 37.93 Cr 0.1476
2025-03-31 99.93 Cr 87.28 Cr 12.55 Cr 0.1256 21.39 Cr 15.99 Cr 34.02 31.35 Cr 0.1600
2024-12-31 95.11 Cr 42.97 Cr 52.14 Cr 0.5482 15.60 Cr 10.40 Cr 22.13 27.93 Cr 0.1093

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 7.89 Cr 84.88 Cr 92.77 Cr 18.25 Cr 12.26 Cr 129.44 Cr 536.68 Cr 728.92 Cr 414.35 Cr
2025-06-30 0.00 Cr 0.00 Cr 24.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -209.61 Cr
2025-03-31 12.17 Cr 12.63 Cr 24.80 Cr 13.97 Cr 13.40 Cr 55.94 Cr 493.08 Cr 613.32 Cr 403.71 Cr
2024-12-31 0.00 Cr 0.00 Cr 14.96 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -184.04 Cr
2024-09-30 14.96 Cr 13.49 Cr 28.45 Cr 16.25 Cr 11.80 Cr 60.95 Cr 451.29 Cr 568.83 Cr 384.79 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 17.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 15.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 10.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 14.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 14.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Care Facilities

Company Name Symbol Price Market Cap Volume
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹7,720.50 ₹1,110,089,444,369.00 ₹377,143.00
Max Healthcare Institute Limited MAXHEALTH ₹1,086.40 ₹1,057,167,990,760.00 ₹2,374,893.00
Fortis Healthcare Limited FORTIS ₹919.55 ₹694,221,764,993.00 ₹609,033.00
Narayana Hrudayalaya Limited NH ₹1,821.00 ₹369,844,799,535.00 ₹268,732.00
Aster DM Healthcare Limited ASTERDM ₹638.00 ₹329,805,509,968.00 ₹295,986.00
Global Health Limited MEDANTA ₹1,149.90 ₹309,082,046,463.00 ₹102,590.00
Krishna Institute of Medical Sciences Limited KIMS ₹735.85 ₹294,442,235,320.00 ₹609,767.00
Rainbow Children's Medicare Limited RAINBOW ₹1,199.10 ₹121,779,588,756.00 ₹42,489.00
Jupiter Life Line Hospitals Limited JLHL ₹1,284.50 ₹84,219,555,259.00 ₹20,122.00
HealthCare Global Enterprises Limited HCG ₹584.70 ₹82,447,165,354.00 ₹59,358.00
Yatharth Hospital & Trauma Care Services Limited YATHARTH ₹704.10 ₹67,843,102,764.00 ₹260,586.00
Indraprastha Medical Corporation Limited INDRAMEDCO ₹401.30 ₹36,788,374,900.00 ₹138,030.00
Artemis Medicare Services Limited ARTEMISMED ₹231.59 ₹36,472,890,711.00 ₹166,732.00
Kovai Medical Center and Hospital Limited KOVAI ₹2,581.00 ₹35,290,787,300.00 ₹5,780.00

Key Executives

Chief Executive Officer & Whole -Time Director
Adil Agarwal

Gender: Not Specified

Year Born: 1983

Founder, Chairman & MD
Amar Agarwal

Gender: Not Specified

Year Born: 1960

Founder & Whole Time Director
Athiya Agarwal

Gender: Not Specified

Year Born: 1955

Head of Digital Marketing
Aman Joshi

Gender: male

Year Born:

Senior Vice President of Operations of South & East India
Nandha Kumar

Gender: male

Year Born:

Senior Vice President of International Operations of BD and M&A
N. R. Ugandhar

Gender: male

Year Born:

Interim Chief Financial Officer
Yashwanth Venkat

Gender: male

Year Born: 1985

Company Secretary & Compliance Officer
Meenakshi Jayaraman

Gender: female

Year Born:

Head of Human Resource
Suhasini K

Gender: female

Year Born:

General Manager of Projects
Terence Leo Seqi

Gender: Not Specified

Year Born: 1977

FAQs about Dr. Agarwal's Eye Hospital Limited

Who is the CEO of the company?

The CEO is Adil Agarwal.

What is the current market price of the stock?

The current price is ₹4,686.45.

What is the 52-week price range?

The range is ₹3512.6-6392.

What is the market capitalization of the company?

The market capitalization is ₹2,202.63 crores.

What is the dividend yield?

The dividend yield is 0.14%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 32.42.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dr. Agarwal's Eye Hospital Limited (ISIN: INE934C01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹2,202.63 crores and an average daily volume of 1,293 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹6.5.